Back to Top
Izenivetmab Biosimilar - Research Grade
$710.00 - $6,900.00
Izenivetmab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
NGF
Concentration
5mg/ml
Isotype
IgG2 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P01138
Shipping Conditions
Blue ice
Background
Nerve growth factor (NGF) is a key neurotrophin in pain signaling and sensory-neuron biology, central to analgesia and neuroscience research. This research-grade reagent is an unconjugated, non-therapeutic analog of izenivetmab, presented as a human IgG2, kappa monoclonal that neutralizes the human protein and is offered for research use only (RUO). It is supplied with low endotoxin for in vivo suitability and manufactured in milligram to gram quantities to meet the needs of bulk and high-throughput laboratories. Investigators apply it in ligand-neutralization and binding assays, in vitro screening, and preclinical pain and neurodegeneration models, where it serves as a consistent functional comparator.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












